| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director
3 companies
Parker Geoffrey M. is a Chief Financial Officer at ALLO, with reported holdings spanning 3 companies. Recent filings cover 15 purchases and 4 sales. Those positions are worth an estimated $2.1M at current prices.
Our model assigns Parker Geoffrey M. a below-average insider score of 46/100, based on 11 past trades. Over a 12-month horizon, 0.0% of those trades were profitable, with an average 12-month return of -24.5%.
Parker Geoffrey M.'s largest disclosed position is in ALLO as Chief Financial Officer, worth about $1.4M. The recent filings there lean toward selling, a net 101,258 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2021 | PRGO Perrigo Co Plc | Director | Buy | 5,000 | $36.85 | $184,270.00 | +85.0% | +4.0% | -12.3% | |
| Mar 17, 2021 | PRGO Perrigo Co Plc | Director | Buy | 2,500 | $41.29 | $103,217.75 | +1,667% | +15.2% | -4.7% | |
| Nov 12, 2018 | PRGO Perrigo Co Plc | Director | Buy | 3,000 | $65.35 | $196,058.10 | +120.0% | - | - | |
| Dec 9, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 3,740 | $3.87 | $14,476.96 | +6.0% | - | - | |
| Nov 21, 2016 | PRGO Perrigo Co Plc | Director | Buy | 2,500 | $88.75 | $221,875.00 | New | - | - | |
| May 26, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 9,500 | $0.47 | $4,454.55 | +18.1% | - | - | |
| May 25, 2016 | VIRX Viracta Therapeutics, Inc. | Director | Buy | 52,505 | $0.47 | $24,813.93 | New | - | - |